{"text": "stocks going ex-dividend the first week of april URL $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm"}
{"text": "stocks going ex-dividend the first week of april $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps\u00a1\u00ad\u00a1\u00ad URL"}
{"text": "stocks going ex-dividend the first week of april $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps\u00a1\u00ad\u00a1\u00ad URL"}
{"text": "stocks going ex-dividend the first week of april URL $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm"}
{"text": "stocks going ex-dividend the first week of april URL $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm"}
{"text": "leerink swann reiterates outperform rating for bristol-myers squibb co $bmy URL #acn"}
{"text": "leerink swann reiterates outperform rating for bristol-myers squibb co $bmy URL"}
{"text": "stocks going ex dividend the first week of april $axp $bks $bmy $dgx $gd $gis $gps $jpm $cmcsa $csco $intu URL"}
{"text": "leerink swann reiterates outperform rating for bristol-myers squibb co $bmy URL"}
{"text": "5 deadliest diseases in the u.s. -- and the top drugs potentially #stocks $mrk, $bmy, $alny, $azn, $biib, $mdco URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "AT_USER entered last wk&amp;adding $35.50&amp;lower;they're projecting robust dataAT_USER for their $bmy prtnrd fpa008;\u00a1\u00ad URL"}
{"text": "$bmy chart looks like it wants more downside. will be watching for a pop to short into this week. #iceman URL"}
{"text": "rt AT_USER #aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "rt AT_USER #aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "rt AT_USER #aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "rt AT_USER #aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "rt AT_USER #aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "rt AT_USER #aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "#aacr17 barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (cont) URL"}
{"text": "rt AT_USER AT_USER it\u00a1\u00afs interesting to watch $mrk &amp; $bmy go all-in with $incy epacadostat. moving more aggressively than roche\u00a1\u00ad"}
{"text": "barclay quick thoughts on the echo update $bmy $incy opdivo + epacadostat moving into phase 3 (c AT_USER URL"}
{"text": "AT_USER insider $bmy sell recently good amount"}
{"text": "AT_USER is this signal that their own anti-ido1 is dead, or they wan't to be in front of the learning curve? $bmy, $incy, $mrk"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "AT_USER it\u00a1\u00afs interesting to watch $mrk &amp; $bmy go all-in with $incy epacadostat. moving more aggressively than roche w/ $nlnk ido."}
{"text": "from a pure competitive standpoint, $bmy is likely compelled to move ahead in an effort to find a niche or two.\u00a1\u00ad URL"}
{"text": "rt AT_USER is now a good time to buy $jpm $esrx $bac $ibm $mpc URL $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2\u00a1\u00ad"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "denver investment advisors llc has $5,972,000 position in bristol-myers squibb co $bmy URL"}
{"text": "princeton portfolio strategies group llc raises position in bristol-myers squibb co $bmy URL"}
{"text": "princeton portfolio strategies group llc raises position in bristol-myers squibb co $bmy URL"}
{"text": "l &amp; s advisors inc takes position in bristol-myers squibb co $bmy URL"}
{"text": "congress asset management co. ma invests $31,628,000 in bristol-myers squibb co $bmy URL"}
{"text": "horizon kinetics llc has $3,073,000 stake in bristol-myers squibb co $bmy URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "#bristolmyerssquibb bristol-myers squibb and incyte to advance the combination of opdivo (ni... read more: URL $bmy"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "AT_USER i thought $bmy had its own ido inhibitor, why collaborate with $incy, maybe the in house inhibitor is not good enough"}
{"text": "#bristolmyerssquibb : and incyte to advance the combination of opdivo (nivolumab) and epacad... read more: URL $bmy"}
{"text": "#bristolmyerssquibb : and incyte to advance the combination of opdivo (nivolumab) and epacad... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb and incyte to advance the combination of opdivo nivo... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristol-myers squibb and incyte to advance the combination of opdivo (ni... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb and incyte to advance the combination of opdivo nivo... read more: URL $bmy"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "bristol-myers squibb co $bmy sees significant drop in short interest URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "rt AT_USER $bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "$bmy and $incy  to advance the combination of opdivo and epacadostat into first-line registrational trials URL"}
{"text": "$bmy bristol-myers squibb and incyte to advance the combination of opdivo (nivolumab) and epacadostat int... - URL"}
{"text": "frontier wealth management llc increases position in bristol-myers squibb co $bmy URL"}
{"text": "bristol-myers squibb co $bmy shares sold by gabelli funds llc URL"}
{"text": "bristol-myers squibb co $bmy sees significant drop in short interest URL"}
{"text": "piper jaffray companies reiterates neutral rating for bristol-myers squibb co $bmy URL"}
{"text": "#bristolmyerssquibb bristolmyers squibb company  pharmaceuticals  healthcare  deals and alli... read more: URL $bmy"}
{"text": "#bristolmyerssquibb bristolmyers squibb company  pharmaceuticals  healthcare  deals and alli... read more: URL $bmy"}
{"text": "rt AT_USER AT_USER  battle for 1l lung dominance begins in mid-2017; by 2h 2018,should have most of pieces fall into place $mrk $bm\u00a1\u00ad"}
{"text": "rt AT_USER lr identified 765 active combo trials that include a pd-1/pd- l1 backbone. $mrk $bmy $celg $azn   $ibb AT_USER unreal nu\u00a1\u00ad"}
{"text": "rt AT_USER AT_USER  battle for 1l lung dominance begins in mid-2017; by 2h 2018,should have most of pieces fall into place $mrk $bm\u00a1\u00ad"}
{"text": "AT_USER  battle for 1l lung dominance begins in mid-2017; by 2h 2018,should have most of pieces fall into place\u00a1\u00ad URL"}
